News
Exelixis Announces Acceptance of New Drug Application for Cobimetinib in Combination with Vemurafenib for Treatment of Patients with BRAF V600 Mutation-Positive Advanced Melanoma
FDA Grants Priority Review, Assigns Action Date of August 11, 2015 - SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Exelixis, Inc. (NASDAQ:EXEL) announced today that the...
Press Releases
Orion Pharma Animal Health and Vetoquinol Enter Distribution Collaboration from 1 January 2015
Orion Pharma Animal Health and Vetoquinol have announced their collaboration regarding the distribution of Orion's sedatives product family alpha-2 agonists and antagonist Dexdomitor, Domitor...
Press Releases
Patheon Adds New Filling Technology to Milton Park Facility
Patheon has added a new filling technology that significantly reduces the time needed for formulation development and stability testing at its facility in Milton...
Press Releases
Patheon Development and Manufacturing Presentation at Global Summit
An expert from Patheon will highlight the company's strategy for delivering exceptional customer experience through its integrated offerings at the Seventh Annual Global Biomanufacturing...
Press Releases
Lonza Announces Agreement for the Supply of TiGenix’s eASC Product Cx601
Lonza has announced an agreement for the supply of TiGenix's eASC product, Cx601. Under the agreement, Lonza will manufacture material for the Phase III...
Press Releases
Boehringer Ingelheim Renews Global Technology Collaboration Agreement with VTU Technology
Boehringer Ingelheim, a research-based, global pharmaceutical company, and VTU Technology, a leading contract research and development company, announced today the renewal of their global...
Press Releases
TxCell reports revenues for 2014 and updates on upcoming milestones
TxCell, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















